Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

A data mining approach to investigate patterns of powered two-wheeler crashes in Spain.

Montella A, de Oña R, Mauriello F, Rella Riccardi M, Silvestro G.

Accid Anal Prev. 2019 Aug 9:105251. doi: 10.1016/j.aap.2019.07.027. [Epub ahead of print]

PMID:
31402051
2.

Branched clonal evolution: nodal follicular lymphoma and primary diffuse large B-cell lymphoma of the central nervous system.

Barranco GI, Fernández S, Oña R, González-Rincón J, Martínez-Ramírez A, Teijo A, Camacho FI, Pinedo FJ, Sánchez-Beato M, Pedrosa L, de la Fuente A, Estévez M, Iglesias R, Montalbán C, García JF.

Haematologica. 2019 Jul;104(7):e326-e329. doi: 10.3324/haematol.2018.214981. Epub 2019 Mar 19. No abstract available.

3.

Differential prognostic impact of GELTAMO-IPI in cell of origin subtypes of Diffuse Large B Cell Lymphoma as defined by the Hans algorithm.

Montalbán C, Díaz-López A, Martín A, Baile M, Sanchez JM, Sancho JM, García O, Novelli S, Monter-Rovira A, Salar A, Bastos M, Gutiérrez A, Bento L, Córdoba R, Arquero T, González de Villambrosia S, Barranco G, De Oña R, López Guillermo A, Rodriguez Salazar MJ, Domínguez JF, Fernández R, Queizan JA, Rodríguez J, Abraira V, García JF; GELTAMO-IPI Project Investigators.

Br J Haematol. 2018 Aug;182(4):534-541. doi: 10.1111/bjh.15446. Epub 2018 Jul 5.

PMID:
29978453
4.

Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of β2 -microglobulin yields a more accurate GELTAMO-IPI.

Montalbán C, Díaz-López A, Dlouhy I, Rovira J, Lopez-Guillermo A, Alonso S, Martín A, Sancho JM, García O, Sánchez JM, Rodríguez M, Novelli S, Salar A, Gutiérrez A, Rodríguez-Salazar MJ, Bastos M, Domínguez JF, Fernández R, Gonzalez de Villambrosia S, Queizan JA, Córdoba R, de Oña R, López-Hernandez A, Freue JM, Garrote H, López L, Martin-Moreno AM, Rodriguez J, Abraira V, García JF; GELTAMO-IPI Project Investigators.

Br J Haematol. 2017 Mar;176(6):918-928. doi: 10.1111/bjh.14489. Epub 2017 Jan 20.

PMID:
28106247
5.

Personal factors influencing the visual reaction time of pedestrians to detect turn indicators in the presence of Daytime Running Lamps.

Peña-García A, de Oña R, García PA, de Oña J.

Ergonomics. 2016 Dec;59(12):1596-1605. Epub 2016 Apr 27.

PMID:
26942500
6.

Evaluation of clinical and biological prognostic factors in relapsed or refractory diffuse large B-cell lymphoma patients after previous treatment with rituximab and chemotherapy: results of the PRO-R-IPI study.

Panizo C, Rodríguez AJ, Gutiérrez G, Díaz FJ, González-Barca E, de Oña R, Grande C, Sancho JM, García-Álvarez MF, Sánchez-González B, Peñalver FJ, Cannata J, Espeso M, Requena MJ, Gardella S, Durán S, González AP, Alfonso A, Caballero MD; Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea GELTAMO Spanish Cooperative Group.

Clin Lymphoma Myeloma Leuk. 2015 Jul;15(7):398-403. doi: 10.1016/j.clml.2015.02.029. Epub 2015 Mar 5.

PMID:
25843416
7.

Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and cyclophosphamide for chronic lymphocytic leukemia.

Garrote H, de la Fuente A, Oña R, Rodríguez I, Echevarría JE, Sepúlveda JM, García JF.

Exp Hematol Oncol. 2015 Mar 1;4:8. doi: 10.1186/s40164-015-0003-4. eCollection 2015.

8.

How to identify the key factors that affect driver perception of accident risk. A comparison between Italian and Spanish driver behavior.

de Oña J, de Oña R, Eboli L, Forciniti C, Mazzulla G.

Accid Anal Prev. 2014 Dec;73:225-35. doi: 10.1016/j.aap.2014.09.020. Epub 2014 Sep 21.

PMID:
25247553
9.

Clinical experience of bendamustine treatment for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Spain.

Sanchez-Gonzalez B, Peñalver FJ, Medina A, Guillén H, Calleja M, Gironella M, Arranz R, Sebastian E, de Oña R, Cánovas A, de la Fuente I, Grande C, Sancho JM, Perez R, Domingo E, Lopez-Lorenzo JL, Prieto E, Panizo C, Gorosquieta A, Perez I, Cervera JM, Marin M, Mencha C, Ramila E, Salar A.

Leuk Res. 2012 Jun;36(6):709-14. doi: 10.1016/j.leukres.2011.10.024. Epub 2011 Dec 7.

PMID:
22154023
10.

Frontline treatment of follicular lymphoma with fludarabine, cyclophosphamide, and rituximab followed by rituximab maintenance: toxicities overcome its high antilymphoma effect. Results from a Spanish Cooperative Trial (LNHF-03).

Tomás JF, Montalbán C, De Sevilla AF, Martínez-López J, Díaz N, Canales M, Martínez R, Sánchez-Godoy P, Caballero MD, Peñalver J, Prieto E, Salar A, Burgaleta C, Queizán JA, Bajo R, De Oña R, De La Serna J.

Leuk Lymphoma. 2011 Mar;52(3):409-16. doi: 10.3109/10428194.2010.543717. Epub 2011 Jan 28.

PMID:
21275633
11.

Relationship between deoxycytidine kinase (DCK) genotypic variants and fludarabine toxicity in patients with follicular lymphoma.

Rivero A, Rapado I, Tomás JF, Montalbán C, de Oña R, Paz-Carreira J, Canales M, Martínez R, Sánchez-Godoy P, de Sevilla AF, de la Serna J, Martínez-López J.

Leuk Res. 2011 Apr;35(4):431-7. doi: 10.1016/j.leukres.2010.09.026. Epub 2010 Oct 27.

PMID:
21030078
12.

[Reticulocyte response after immediate withdrawal of recombinant human erythropoietin in chronic hemodialysis patients].

Caramelo C, Soto C, Neira F, López MD, Jiménez S, Albalate M, de Oña R, Llamas P, Deudero JJ.

Nefrologia. 2004;24(4):351-6. Spanish.

13.

[Prothrombotic factors in stroke].

Meseguer E, Llamas P, Fernández de Velasco J, García A, Echevarria A, Oña R, Rábano J, Tomas JF, García de Yébenes J.

Neurologia. 2004 Apr;19(3):99-105. Spanish.

PMID:
15088159
14.

Long-term effects of a maintenance program after supervised or self-monitored training programs in patients with COPD.

Puente-Maestu L, Luisa Sánz M, Sánz P, de Oña RJ, Arnedillo A, Casaburi R.

Lung. 2003;181(2):67-78.

PMID:
12953145
15.

Evaluation of thrombophylic states in myeloma patients receiving thalidomide: a reasonable doubt.

Santos AB, Llamas P, Román A, Prieto E, De Oña R, De Velasco JF, Tomás JF.

Br J Haematol. 2003 Jul;122(1):159-60. No abstract available.

PMID:
12823358
16.

Masked imidazole groups in cyanoferrihemoglobin and carbonylhemoglobin.

STEINHARDT J, ONA R, BEYCHOK S.

Biochemistry. 1962 Jan;1:29-34. No abstract available.

PMID:
13916758

Supplemental Content

Support Center